Cargando…
Focal adhesion alterations in G0‐positive melanoma cells
BACKGROUND: Melanoma is a highly heterogeneous malignant tumor that exhibits various forms of drug resistance. Recently, reversal transition of cancer cells to the G(0) phase of the cell cycle under the influence of therapeutic drugs has been identified as an event associated with tumor disseminatio...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10067123/ https://www.ncbi.nlm.nih.gov/pubmed/36533319 http://dx.doi.org/10.1002/cam4.5510 |
_version_ | 1785018403303456768 |
---|---|
author | Esimbekova, Alexandra R. Palkina, Nadezhda V. Zinchenko, Ivan S. Belenyuk, Vasiliy D. Savchenko, Andrey A. Sergeeva, Ekaterina Yu Ruksha, Tatiana G. |
author_facet | Esimbekova, Alexandra R. Palkina, Nadezhda V. Zinchenko, Ivan S. Belenyuk, Vasiliy D. Savchenko, Andrey A. Sergeeva, Ekaterina Yu Ruksha, Tatiana G. |
author_sort | Esimbekova, Alexandra R. |
collection | PubMed |
description | BACKGROUND: Melanoma is a highly heterogeneous malignant tumor that exhibits various forms of drug resistance. Recently, reversal transition of cancer cells to the G(0) phase of the cell cycle under the influence of therapeutic drugs has been identified as an event associated with tumor dissemination. In the present study, we investigated the ability of chemotherapeutic agent dacarbazine to induce a transition of melanoma cells to the G(0) phase as a mechanism of chemoresistance. METHODS: We used the flow cytometry to analyze cell distribution within cell cycle phases after dacarbazine treatment as well as to identifyG(0)‐positive cells population. Transcriptome profiling was provided to determine genes associated with dacarbazine resistance. We evaluated the activity of β‐galactosidase in cells treated with dacarbazine by substrate hydrolysis. Cell adhesion strength was measured by centrifugal assay application with subsequent staining of adhesive cells with Ki‐67 monoclonal antibodies. Ability of melanoma cells to metabolize dacarbazine was determined by expressional analysis of CYP1A1, CYP1A2, CYP2E1 followed by CYP1A1 protein level evaluation by the ELISA method. RESULTS: The present study determined that dacarbazine treatment of melanoma cells could induce an increase in the percentage of cells in G(0) phase without alterations of β‐galactosidase positive cells which corresponded to the fraction of the senescent cells. Transcriptomic profiling of cells under dacarbazine induction of G(0)‐positive cells percentage revealed that ‘VEGFA‐VEGFR2 signaling pathway’ and ‘Cell cycle’ signaling were mostly enriched by dysregulated genes. ‘Focal adhesion’ signaling was also found to be triggered by dacarbazine. In melanoma cells treated with dacarbazine, an increase in G(0)‐positive cells among adherent cells was found. CONCLUSIONS: Dacarbazine induces the alteration in a percentage of melanoma cells residing in G(0) phase of a cell cycle. The altered adhesive phenotype of cancer cells under transition in the G(0) phase may refer to a specific intercellular communication pattern of quiescent/senescent cancer cells. |
format | Online Article Text |
id | pubmed-10067123 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-100671232023-04-03 Focal adhesion alterations in G0‐positive melanoma cells Esimbekova, Alexandra R. Palkina, Nadezhda V. Zinchenko, Ivan S. Belenyuk, Vasiliy D. Savchenko, Andrey A. Sergeeva, Ekaterina Yu Ruksha, Tatiana G. Cancer Med RESEARCH ARTICLES BACKGROUND: Melanoma is a highly heterogeneous malignant tumor that exhibits various forms of drug resistance. Recently, reversal transition of cancer cells to the G(0) phase of the cell cycle under the influence of therapeutic drugs has been identified as an event associated with tumor dissemination. In the present study, we investigated the ability of chemotherapeutic agent dacarbazine to induce a transition of melanoma cells to the G(0) phase as a mechanism of chemoresistance. METHODS: We used the flow cytometry to analyze cell distribution within cell cycle phases after dacarbazine treatment as well as to identifyG(0)‐positive cells population. Transcriptome profiling was provided to determine genes associated with dacarbazine resistance. We evaluated the activity of β‐galactosidase in cells treated with dacarbazine by substrate hydrolysis. Cell adhesion strength was measured by centrifugal assay application with subsequent staining of adhesive cells with Ki‐67 monoclonal antibodies. Ability of melanoma cells to metabolize dacarbazine was determined by expressional analysis of CYP1A1, CYP1A2, CYP2E1 followed by CYP1A1 protein level evaluation by the ELISA method. RESULTS: The present study determined that dacarbazine treatment of melanoma cells could induce an increase in the percentage of cells in G(0) phase without alterations of β‐galactosidase positive cells which corresponded to the fraction of the senescent cells. Transcriptomic profiling of cells under dacarbazine induction of G(0)‐positive cells percentage revealed that ‘VEGFA‐VEGFR2 signaling pathway’ and ‘Cell cycle’ signaling were mostly enriched by dysregulated genes. ‘Focal adhesion’ signaling was also found to be triggered by dacarbazine. In melanoma cells treated with dacarbazine, an increase in G(0)‐positive cells among adherent cells was found. CONCLUSIONS: Dacarbazine induces the alteration in a percentage of melanoma cells residing in G(0) phase of a cell cycle. The altered adhesive phenotype of cancer cells under transition in the G(0) phase may refer to a specific intercellular communication pattern of quiescent/senescent cancer cells. John Wiley and Sons Inc. 2022-12-19 /pmc/articles/PMC10067123/ /pubmed/36533319 http://dx.doi.org/10.1002/cam4.5510 Text en © 2022 The Authors. Cancer Medicine published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | RESEARCH ARTICLES Esimbekova, Alexandra R. Palkina, Nadezhda V. Zinchenko, Ivan S. Belenyuk, Vasiliy D. Savchenko, Andrey A. Sergeeva, Ekaterina Yu Ruksha, Tatiana G. Focal adhesion alterations in G0‐positive melanoma cells |
title | Focal adhesion alterations in G0‐positive melanoma cells |
title_full | Focal adhesion alterations in G0‐positive melanoma cells |
title_fullStr | Focal adhesion alterations in G0‐positive melanoma cells |
title_full_unstemmed | Focal adhesion alterations in G0‐positive melanoma cells |
title_short | Focal adhesion alterations in G0‐positive melanoma cells |
title_sort | focal adhesion alterations in g0‐positive melanoma cells |
topic | RESEARCH ARTICLES |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10067123/ https://www.ncbi.nlm.nih.gov/pubmed/36533319 http://dx.doi.org/10.1002/cam4.5510 |
work_keys_str_mv | AT esimbekovaalexandrar focaladhesionalterationsing0positivemelanomacells AT palkinanadezhdav focaladhesionalterationsing0positivemelanomacells AT zinchenkoivans focaladhesionalterationsing0positivemelanomacells AT belenyukvasiliyd focaladhesionalterationsing0positivemelanomacells AT savchenkoandreya focaladhesionalterationsing0positivemelanomacells AT sergeevaekaterinayu focaladhesionalterationsing0positivemelanomacells AT rukshatatianag focaladhesionalterationsing0positivemelanomacells |